rdf:type |
|
lifeskim:mentions |
umls-concept:C0003289,
umls-concept:C0011570,
umls-concept:C0015259,
umls-concept:C0018799,
umls-concept:C0027361,
umls-concept:C0033213,
umls-concept:C0087111,
umls-concept:C0162340,
umls-concept:C0220901,
umls-concept:C0814225,
umls-concept:C1706387,
umls-concept:C1707689
|
pubmed:issue |
5
|
pubmed:dateCreated |
2007-10-18
|
pubmed:abstractText |
Depression is relatively common in patients with coronary heart disease (CHD) and is associated with worse prognosis. Recently there has been interest in evaluating the impact of treating depression on clinical outcomes. Anti-depressant medications have been shown to be safe and efficacious for many patients; exercise also may be effective for treating depression and may also improve cardiopulmonary functioning. However, methodological limitations of previous studies have raised questions about the value of exercise, and no study has compared the effects of exercise with standard anti-depressant medication in depressed cardiac patients.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1740-7745
|
pubmed:author |
pubmed-author:BabyakMichael AMA,
pubmed-author:BlumenthalJames AJA,
pubmed-author:DoraiswamyP MuraliPM,
pubmed-author:HinderliterAlanA,
pubmed-author:HoffmanBenson MBM,
pubmed-author:JohnsonJulie JJJ,
pubmed-author:O'ConnellCaraC,
pubmed-author:PatidarSeema MSM,
pubmed-author:RogersSharon DSD,
pubmed-author:SherwoodAndrewA,
pubmed-author:WatkinsLanaL,
pubmed-author:WaughRobertR
|
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
548-59
|
pubmed:meshHeading |
pubmed-meshheading:17942470-Adult,
pubmed-meshheading:17942470-Antidepressive Agents,
pubmed-meshheading:17942470-Biological Markers,
pubmed-meshheading:17942470-Depression,
pubmed-meshheading:17942470-Endpoint Determination,
pubmed-meshheading:17942470-Exercise,
pubmed-meshheading:17942470-Female,
pubmed-meshheading:17942470-Heart Diseases,
pubmed-meshheading:17942470-Humans,
pubmed-meshheading:17942470-Male,
pubmed-meshheading:17942470-Placebos,
pubmed-meshheading:17942470-Randomized Controlled Trials as Topic,
pubmed-meshheading:17942470-Sertraline,
pubmed-meshheading:17942470-United States
|
pubmed:year |
2007
|
pubmed:articleTitle |
Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues.
|
pubmed:affiliation |
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA. Blume003@mc.duke.edu
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, N.I.H., Extramural
|